Amdocs (NASDAQ:DOX) posts Q3 CY2026 sales in line with estimates but stock drops 40.3%
Amdocs (DOX) reported Q3 CY2026 revenue of $1.19B, meeting estimates, with a 3.8% YoY increase. However, Q4 guidance of $975M missed expectations by 18.7%. Adjusted EPS was $1.98, in line with estimates. The stock dropped 40.3% post-earnings. CEO highlighted new strategic deals, including an 8-year agreement with AT&T.
How this was made

The 30-second read
Why it matters
The earnings miss and weak guidance triggered a 40% price decline, indicating immediate market reaction.
Market read
Amdocs' earnings and guidance miss are the primary drivers of the stock's sharp move, with potential ripple effects in the telecom software sector.
What to watch
Amdocs' new aOS deals with AT&T, Vodafone, VEON, and Globe could drive mid‑term growth despite short‑term guidance miss.
Background
Amdocs is a leading provider of telecom software solutions, recently announcing strategic agreements with major carriers.
Ticker impact
Amdocs reported Q3 CY2026 results in line with estimates but issued Q4 guidance 18.7% below consensus, causing a 40.3% share drop.
likely further downside as investors price in weak Q4 outlook
Guidance shortfall is material and the stock already fell 40% on the news; market reaction is expected to continue.
Market effects
Telecom software sector may see broader scrutiny of guidance expectations.
North American tech indices could face short-term pressure.
Limited to investors tracking telecom software and enterprise software stocks.
Counterpoint
The stock may be oversold; a deeper pullback could set up a buying opportunity if guidance improves.
Key entities
- companyAmdocs
Telecom software provider reporting Q3 CY2026 results.
- partnerAT&T
Largest customer in a new eight‑year strategic agreement.


